KAIST researchers developed a modular organ-on-a-chip that reproduces rhabdomyolysis, revealing how drug-induced muscle ...
Modern biology is driven by technology, explains Philip J. Lee, Ph.D., co-founder, president, and director of research at CellASIC a five-year-old company that develops microfluidic technologies for ...
The use of space environment to carry out life science research is of great significance to issues affecting the occurrence and development of life on earth by space flight and space environment; ...
Interest in cell therapy has increased in recent years, with additional focus on leveraging this as a strategy to fight tumors by harnessing the immune system. Cell therapy technologies include ...
KAIST demonstrates potential to predict drug side effects and acute kidney injury using a small chip
Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly ...
In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback